Aphton (apht) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aphton (apht)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mason630 who wrote (52)	2/23/1998 5:45:00 PM
From: rocket	Read Replies (1) of 95

Mason630--its always been difficult to get much of a thread going re: aphton, probably because it is such a low profile company. However, as best I can tell, the science is great, there are ongoing successes in the clinical trials and the company has set new standards for the biotech industry regarding the percentage of profits they will be able to retain after their products become commercialized. The reason the stock price languishes is because there are very few institutional investors or brokerage firms that follow the stock. As phase iii trials for gastrimmune's use in stomach cancer are completed the company's anonymity should end and patient investors will be rewarded. Don't know the exact time frame but I surmise the stock price will be significantly higher before the end of next year. Best wishes. karl

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next